180 related articles for article (PubMed ID: 27717097)
1. p16 immunostaining in keratinocytic neoplasia in organ transplant recipients: Bowen's disease shows a characteristic pattern.
Genders RE; Beck S; Bouwes Bavinck JN; van den Munckhof HA; Kouwenhoven ST; de Koning MN; de Gruijl FR; Jenkins D; Willemze R; Quint KD
J Cutan Pathol; 2017 Jan; 44(1):28-33. PubMed ID: 27717097
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical staining for p16 is a useful adjunctive test in the diagnosis of Bowen's disease.
Harvey NT; Leecy T; Wood BA
Pathology; 2013 Jun; 45(4):402-7. PubMed ID: 23635817
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of p63, p16, and p53 immunohistochemistry in distinguishing seborrheic keratosis, actinic keratosis, and Bowen's disease.
Nasiri S; Azhari V; Bidari-Zerehpoosh F; Asadi-Kani Z; Talebi A
Dermatol Ther; 2021 Mar; 34(2):e14817. PubMed ID: 33497503
[TBL] [Abstract][Full Text] [Related]
4. Atypical intraepidermal keratinocytic lesions falling short of carcinoma in situ (Bowen disease) on routine staining: the utility of p16 immunostaining.
Ko C; Srisuttiyakorn C
J Cutan Pathol; 2014 Dec; 41(12):975-7. PubMed ID: 25558038
[No Abstract] [Full Text] [Related]
5. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
6. p16INK4a expression in actinic keratosis and Bowen's disease.
Salama ME; Mahmood MN; Qureshi HS; Ma C; Zarbo RJ; Ormsby AH
Br J Dermatol; 2003 Nov; 149(5):1006-12. PubMed ID: 14632806
[TBL] [Abstract][Full Text] [Related]
7. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
Talghini S; Halimi M; Baybordi H
Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease.
Bagazgoitia L; Cuevas J; Juarranz A
J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):228-30. PubMed ID: 19515076
[TBL] [Abstract][Full Text] [Related]
9. Different Immunohistochemical Localization of Fatty Acid Binding Protein 5 in Actinic Keratosis Compared with That in Bowen's Disease: A Retrospective Study.
Ahn B; Kim CH; Chae YS; Lee JH; Lee Y; Ahn HH; Lee YJ
Am J Dermatopathol; 2021 May; 43(5):356-361. PubMed ID: 33055535
[TBL] [Abstract][Full Text] [Related]
10. Comparison of oxidative stress on DNA, protein and lipids in patients with actinic keratosis, Bowen's disease and squamous cell carcinoma.
Yoshifuku A; Fujii K; Kanekura T
J Dermatol; 2018 Nov; 45(11):1319-1323. PubMed ID: 30222205
[TBL] [Abstract][Full Text] [Related]
11. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 and p16 Immunostaining Differentiates Pagetoid Bowen Disease From "Microclonal" Seborrheic Keratosis.
Bahrani E; Sitthinamsuwan P; McCalmont TH; Pincus LB
Am J Clin Pathol; 2019 May; 151(6):551-560. PubMed ID: 30852607
[TBL] [Abstract][Full Text] [Related]
14. In vivo microvascular imaging of cutaneous actinic keratosis, Bowen's disease and squamous cell carcinoma using dynamic optical coherence tomography.
Themstrup L; Pellacani G; Welzel J; Holmes J; Jemec GBE; Ulrich M
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1655-1662. PubMed ID: 28502083
[TBL] [Abstract][Full Text] [Related]
15. An assessment of the malignant potential of actinic keratoses and Bowen's disease: p53 and PCNA expression pattern correlate with the number of desmosomes.
Ramzi ST; Maruno M; Khaskhely NM; Khan MA; Takamiyagi A; Uezato H; Nonaka S
J Dermatol; 2002 Sep; 29(9):562-72. PubMed ID: 12392064
[TBL] [Abstract][Full Text] [Related]
16. Expression of p16 protein in lesional and perilesional condyloma acuminata and bowenoid papulosis: clinical significance and diagnostic implications.
Kazlouskaya V; Shustef E; Allam SH; Lal K; Elston D
J Am Acad Dermatol; 2013 Sep; 69(3):444-9. PubMed ID: 23706650
[TBL] [Abstract][Full Text] [Related]
17. Expression of G1/S-cyclins and cyclin-dependent kinase inhibitors in actinic keratosis and squamous cell carcinoma.
Brasanac D; Stojkovic-Filipovic J; Bosic M; Tomanovic N; Manojlovic-Gacic E
J Cutan Pathol; 2016 Mar; 43(3):200-10. PubMed ID: 26349899
[TBL] [Abstract][Full Text] [Related]
18. Expression of Minichromosome Maintenance Proteins in Actinic Keratosis and Squamous Cell Carcinoma.
Stojkovic-Filipovic J; Brasanac D; Bosic M; Boricic N; Lekic B
Appl Immunohistochem Mol Morphol; 2018 Mar; 26(3):165-172. PubMed ID: 27299186
[TBL] [Abstract][Full Text] [Related]
19. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
[TBL] [Abstract][Full Text] [Related]
20. Phasor-FLIM as a Screening Tool for the Differential Diagnosis of Actinic Keratosis, Bowen's Disease, and Basal Cell Carcinoma.
Luo T; Lu Y; Liu S; Lin D; Qu J
Anal Chem; 2017 Aug; 89(15):8104-8111. PubMed ID: 28661125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]